Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.

Slides:



Advertisements
Similar presentations
The Evolution of an electronic Patient Information System at the Tygerberg Hospital Infectious Diseases Clinic M la Grange 10 December 2009 University.
Advertisements

Loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi: Understanding outcomes and reasons Hannock Tweya, Salem Gugsa, Mina Hosseinipour,
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
East Africa DATA East African IeDEA PI Meeting Zanzibar, Tanzania May 4, 2010 Beverly Musick Regional Data Manager.
Urgent need to strengthen active tracing of lost to follow up cases: a prospective cohort study of newly diagnosed HIV clients in rural districts, Zambia.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.
Community adherence support sustains improved three year outcomes for children on ART A. Grimwood 1, G. Fatti 1, E. Mothibi 1, M. Malahlela.
Primary Healthcare Facilities Deliver More Effective Antiretroviral Therapy: An Evaluation in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Decentralization of HIV care and treatment services in Central Province, Kenya: Adult patient characteristics and outcomes Presenting author: William Reidy,
Preliminary findings of a routine PMTCT Option B+ programme in a rural district in Malawi Rebecca M. Coulborn 1, Laura Triviño Duran 1, Carol Metcalf 2,
Validating five questions of antiretroviral non-adherence in a decentralized public-sector antiretroviral treatment program in rural South Africa Krisda.
Tracking of Inter-Facility Patient Transfers and Retention on Antiretroviral Treatment in Namibia Presenter Naita Nashilongo Ministry of Health and Social.
Outcomes among patients treated for tuberculosis in Limpopo Province, South Africa, Mmakgotso Pilane, Lazarus Kuonza, Eric Maimela.
Attrition in HIV Care Attrition in HIV Care: Key Operational Challenge in implementing HIV Care and Treatment in Tanzania G R Somi _________ Ministry of.
Case Series of HIV-infected children with Bacillus Calmette-Guérin Vaccine Related Lymphadenopathy in Lilongwe, Malawi John Midturi Kazembe, PN., Schutze,
Catherine Kober Margaret Johnson Martin Fisher Caroline Sabin On behalf of UK-CHIC BHIVA/BASHH Manchester 2010 Non-uptake of HAART among patients with.
Management and Development for Health (MDH)
Data from the Collaborative HIV Paediatric Study (CHIPS) Reports up to May 2005.
Orientation on HIV care and ART Recording and Reporting System.
Impact of Highly Active Antiretroviral Therapy on the Incidence of HIV- encephalopathy among perinatally- infected children and adolescents. Kunjal Patel,
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
Factors Associated with Survival in HIV-Infected African Patients on Antiretroviral Therapy: The Impact of a Sampling-Based Approach to Address Losses.
Good Three-year Outcomes of Antiretroviral Therapy at Multiple NGO- assisted facilities in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children Heidi M.
Retention in Care among HIV-infected Patients Receiving Antiretroviral Therapy in Africa: Estimation via a Sampling-based Approach Elvin Geng 1, David.
Failure to Initiate ART, Loss to Follow-up and Mortality among HIV-infected Patients during the pre-ART period in Uganda Elvin H. Geng 1, Winnie Muyindike.
Data from the Collaborative HIV Paediatric Study (CHIPS) Reports up to March 2006* *Numbers are based on reports received rather than children seen to.
Risk of death among those awaiting treatment for HIV infection in Zimbabwe: adolescents are at particular risk ZIMA CONGRESS AUGUST 2015 VICTORIA.
Task-shifting of HIV care and ART initiation: Three year evaluation of a mixed-care provider model for ART delivery Megan McGuire 1, Jihane Ben-Farhat.
Declines in adult HIV mortality in Botswana, : evidence for an impact of antiretroviral therapy programs Rand Stoneburner, Dominic Montagu, Cyril.
Poor linkage to care despite significant improvement in access to early cART – data from Test and Keep in Care (TAK) project. Leah Shepherd, Magdalena.
Survival Analysis approach in evaluating the efficacy of ARV treatment in HIV patients at the Dr GM Hospital in Tshwane, GP of S. Africa Marcus Motshwane.
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
Outcomes in ART treatment programmes with and without access to routine viral load monitoring Olivia Keiser on behalf of IeDEA Southern Africa
Community-Based Adherence Support Associated with Improved Virological Suppression in Adults Receiving ART: Five-Year Outcomes from a South African Multicentre.
Retention in care and connection to care among HIV-infected patients receiving ART n Africa: Estimation via a sampling-based approach Elvin Geng 1, David.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Yield and impact of repeated screening for tuberculosis and isoniazid preventive therapy among patients.
Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.
TB and HIV integrated services at Martin Preuss Centre in Lilongwe, Malawi : “The Lighthouse Trust initiative” Dr Sam Phiri Executive Director Lighthouse.
WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.
No Success without Retension John F. Kennedy Medical Center 11-Jun-16 JFK-ESTHER1.
1 Uses of Data from the WHO HIV Drug Resistance Strategy: 1. Monitoring of HIVDR emerging in treated groups in sentinel ART clinics HIV Drug Resistance.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
Attrition between TB / HIV testing and linkage to care in South Africa’s correctional facilities. 01 December 2015 Vincent Zishiri, Salome Charalambous,
Successfully enrolled in HIV Care but not linked to timely Treatment: Poor retention and Monitoring of Pre-ART patients who are not yet eligible for ART.
Mortality during the first year of HAART in HIV-1-infected patients in 7 countries from Latin America and the Caribbean Suely H. Tuboi, MD, PhD On behalf.
Do Adolescents Equally Utilize PMTCT Services as Adult Women? Data from Patient Tracking Database in Zimbabwe 18 th ICASA, Harare 3 December 2015 Reuben.
Improving Patients Retention in Antiretroviral Treatment Programs: The experience of ARV Programs in Côte d’Ivoire Eugène MESSOU, MD, PhD CePReF- Aconda.
Retention in an antiretroviral program in the Democratic Republic of Congo Kalenga Lucien Koole Olivier Menten Joris Kiumbu Modeste Robin Ryder Mukumbi.
HIV Drug Resistance Surveillance Satellite Session: HIV Drug Resistance Surveillance and Control: a Global Concern Silvia Bertagnolio, MD WHO,
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
Factors associated with loss to follow up in a primary healthcare clinic practicing test and treat Authors: Julius Kiwanuka1,2, Noah Kiwanuka3, Flavia.
A Way out of Directly Observed Therapy (DOT): Community approaches to Self-Administered Treatment for Rifampicin Resistant Tuberculosis in Khayelitsha,
Earlier treatment and lower mortality in infants Initiating ART at
Impact of HIV on Loss to Follow-up and Survival among children with Lymphoma in Malawi Christopher Chikhosi Stanley, MSc Malawi Cancer Symposium
Factors affecting virological failure in patients receiving antiretroviral therapy: a prospective HIV Clinical cohort in rural Uganda. Patrick Kazooba1,
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Validating Definitions of Antiretroviral Treatment Failure in Malawi
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
Annex 3: Patient Tracking (or Tracing) Procedures
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Juan Gonzalez Perez AIDS Healthcare Foundation
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Community patient tracking by Lay Community Health Workers (CHWs) is an effective strategy towards the 2nd & 3rd 90 Morapedi Boitumelo M.
Knowing your epidemic and knowing your response – maximising routinely collected data to measure and monitor HIV epidemics in sub-Saharan Africa Monitoring.
24 July 2018 Treatment outcomes with bedaquiline use when substituted for second-line injectables in multidrug resistant tuberculosis: a retrospective.
Management and Development for Health (MDH)
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Presentation transcript:

Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S. Phiri, R. Weigel

Lost to follow-up in ART programmes Lost to follow-up (LTFU) is common in ART programmes in sub-Saharan Africa –21% in the first 6 months –26-30% in the first 2 years LTFU can lead to treatment interruptions –Development of viral resistance to ART –Hamper HIV prevention efforts Limited information regarding LTFU in children

Objectives To explore factors associated with LTFU in children accessing ART To describe children’s true ART outcomes as determined through Back-To-Care project

Methods: Study Setting Lighthouse and Martin Preuss centre (MPC) clinics: large, public HIV/AIDS clinics in Lilongwe, Malawi Lighthouse and MPC use electronic data systems (EDS) All HIV-infected patients are registered in the EDS Visits are initially scheduled monthly then extended to 2 months for ART patients At each visit, number of remaining ARV pills and new supply are recorded and next appointment is electronically calculated

Methods: Back-To-Care Active tracing of LTFU patients was established in July 2006 – called Back-To-Care (B2C) project The B2C program intends to decrease treatment interruption and prevent loss to follow-up Every month, B2C staff generate a list of patients that miss an appointment by at least 3 weeks B2C team confirms the list by checking in patients files Patients who consent are traced up to 3 times by phone or home visit

Methods: B2C Data Collection B2C tracing staff complete paper forms on tracing efforts Information on tracing outcomes and future patient intention of ART are entered in B2C MS Access database B2C data linked to the EDS using unique identifiers –To identify patients who return after tracing

Methods: Analysis ART outcomes for national programme include transfer out, LTFU, ART stop, death and alive on ART B2C outcomes include death, uninterrupted therapy, on ARV with gaps, official transfer out, self transfer out, ART stop, never started ART and not traced Patients were censored on –Last clinic visit date –Outcome date ( death) Cox proportional hazard model was used to identify independent risk factors for LTFU among baseline patient characteristics

Results: Patients details Between Apr 2006 and Dec 2010, 1182 children accessed ART at Lighthouse and MPC clinics –197 were then excluded from analysis due to incomplete or inaccurate data Of the 985 included in the analysis, –1,999 children-years of follow-up –48% were male –Median age at ART initiation 81 months (IQR: )

Results: LTFU 251 (25%) had at least one missed appointment –Median follow-up time was 9 months (IQR: months) LTFU rate was 12.6/100 children-years –11.8% at 6 months; 16.8% at 12 months Risk factors for LTFU in multivariable analysis –Wasting (AHR % CI ) –< 2 years at ART start (AHR % CI 1.02 – 2.37) No statistically significant association with –Gender, distance to clinic, advanced WHO stage

Results: B2C tracing * No significant differences between those included in B2C list or not, or between those traced or not 201 in B2C 158 (78,6%) Successfully Traced 43 (21,4%) Not traced / Not found 17 (10,8%) Died 41 (25,9%) TO 100 (63,3%) Alive not TO 38 (93%) Official 3 (7%) ‘Silent’ 2 Never started ART 39 Stop ART 31 On ART Uninterrupted 28 On ART with Gaps

ART outcomes before/after correcting for true outcomes of LTFU children actively traced by the B2C team Results: ART outcomes 80% of children expected after tracing returned Alive on ART LTFU Died Stopped ART Transfer Out

Conclusions Majority of LTFU children were alive but had missed appointments –May be due to less capable or motivated guardians Wasting and young age (<2 years) were associated with higher rate of LTFU Lower mortality rate (11%) among children traced compared to other studies Higher proportion of official transfer-outs compared to other studies but similar to adults – poor documentation After tracing, LTFU rate reduced by 62% and mortality estimates increased from 2.6% to 4.8%

Recommendations Active LTFU of children on ART should be encouraged –Reduces LFTU rates –Increases retention –Improves mortality estimates Transfer out patients should be better documented to prevent unnecessary tracing

Acknowledgments